AU2001260255A1 - Cephalosporin intermediates - Google Patents

Cephalosporin intermediates

Info

Publication number
AU2001260255A1
AU2001260255A1 AU2001260255A AU6025501A AU2001260255A1 AU 2001260255 A1 AU2001260255 A1 AU 2001260255A1 AU 2001260255 A AU2001260255 A AU 2001260255A AU 6025501 A AU6025501 A AU 6025501A AU 2001260255 A1 AU2001260255 A1 AU 2001260255A1
Authority
AU
Australia
Prior art keywords
compound
formula
cephalosporin intermediates
cephalosporin
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001260255A
Inventor
Peter Kremminger
Johannes Ludescher
Siegfried Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz GmbH
Original Assignee
Biochemie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie GmbH filed Critical Biochemie GmbH
Publication of AU2001260255A1 publication Critical patent/AU2001260255A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A process which comprises(i) acylating a compound of formula IIwith a compound of formula IVto obtain a compound of formula Iand(ii) deformylating said compound of formula I to obtain a compound of formula III
AU2001260255A 2000-04-28 2001-04-26 Cephalosporin intermediates Abandoned AU2001260255A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0010475.2A GB0010475D0 (en) 2000-04-28 2000-04-28 Organic compounds
GB0010475 2000-04-28
PCT/EP2001/004735 WO2001083491A1 (en) 2000-04-28 2001-04-26 Cephalosporin intermediates

Publications (1)

Publication Number Publication Date
AU2001260255A1 true AU2001260255A1 (en) 2001-11-12

Family

ID=9890746

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001260255A Abandoned AU2001260255A1 (en) 2000-04-28 2001-04-26 Cephalosporin intermediates

Country Status (12)

Country Link
US (1) US6787649B2 (en)
EP (1) EP1278754B1 (en)
JP (1) JP4990462B2 (en)
KR (1) KR100789156B1 (en)
CN (1) CN1195761C (en)
AT (1) ATE287889T1 (en)
AU (1) AU2001260255A1 (en)
CA (1) CA2405621C (en)
DE (1) DE60108627T2 (en)
GB (1) GB0010475D0 (en)
TW (1) TWI281920B (en)
WO (1) WO2001083491A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101045733B (en) * 2007-01-26 2011-11-16 浙江永宁药业股份有限公司 Preparation method of cefotiam chloride
CN101633666B (en) * 2009-08-26 2010-08-18 海南永田药物研究院有限公司 Cefotiam hydrochloride compound in new path
CN102190667B (en) 2011-03-24 2013-05-29 海南灵康制药有限公司 New method for purifying cefotiam hydrochloride
CN102898441A (en) * 2012-10-11 2013-01-30 南通康鑫药业有限公司 Method for synthesizing cefotiam
CN102977123B (en) * 2012-12-03 2015-04-29 邓世碧 Cephalosporins compound and pharmaceutically acceptable salt thereof
CN103012436B (en) * 2012-12-04 2015-07-01 山东鑫泉医药有限公司 Preparation method of cefotiam hydrochloride
CN103232477B (en) * 2013-05-08 2014-04-09 四川省惠达药业有限公司 Cefotiam hydrochloride compound, and preparation method and pharmaceutical composition thereof
CN103601737B (en) * 2013-12-04 2016-02-03 哈药集团制药总厂 A kind of preparation method of cefotiam hydrochloride
CN105125558A (en) * 2015-09-18 2015-12-09 青岛华之草医药科技有限公司 Antibacterial cefotiam hydrochloride drug composition
CN105820162B (en) * 2016-05-12 2019-01-08 浙江永宁药业股份有限公司 A kind of synthetic method of Cefotiam process impurity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341775A (en) * 1978-09-11 1982-07-27 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
EP0088454B1 (en) * 1979-09-03 1986-03-05 Fujisawa Pharmaceutical Co., Ltd. New starting compounds for preparing cephem compounds and processes for their preparation
NZ208281A (en) * 1983-06-02 1986-11-12 Takeda Chemical Industries Ltd Cephalosporin ester derivatives and pharmaceutical compositions
JPS6011490A (en) * 1983-06-24 1985-01-21 Sagami Chem Res Center Beta-lactam derivative
IT1265341B1 (en) 1993-07-16 1996-11-22 Farmabios Srl PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINE
JPH10510258A (en) * 1994-12-09 1998-10-06 藤沢薬品工業株式会社 Cephem compounds and their pharmaceutical uses

Also Published As

Publication number Publication date
GB0010475D0 (en) 2000-06-14
KR100789156B1 (en) 2007-12-28
CN1426416A (en) 2003-06-25
EP1278754B1 (en) 2005-01-26
CN1195761C (en) 2005-04-06
KR20030005274A (en) 2003-01-17
TWI281920B (en) 2007-06-01
JP2003531911A (en) 2003-10-28
ATE287889T1 (en) 2005-02-15
EP1278754A1 (en) 2003-01-29
US6787649B2 (en) 2004-09-07
JP4990462B2 (en) 2012-08-01
WO2001083491A1 (en) 2001-11-08
CA2405621A1 (en) 2001-11-08
CA2405621C (en) 2009-12-15
DE60108627T2 (en) 2005-12-29
US20030153748A1 (en) 2003-08-14
DE60108627D1 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
AU2003229953A1 (en) Phthalazinone derivatives
SE0000540D0 (en) New compounds
WO2001019828A3 (en) Kinase inhibitors as therapeutic agents
GB0127903D0 (en) Improvements relating to organic compounds
AU2001260255A1 (en) Cephalosporin intermediates
AU8350698A (en) Metalloproteinase inhibitors
SG144736A1 (en) Synthesis of temozolomide and analogs
BG105348A (en) PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
SI1181294T1 (en) Novel derivatives and analogues of galanthamin
SG143062A1 (en) Synthesis of temozolomide and analogs
RS8604A (en) Process for the production of beraprost and its salts
AU1394802A (en) Novel process
MXPA04000771A (en) Method for the nitration of phenolic compounds.
MXPA03002493A (en) Efficient process for the preparation of a factor xa inhibitor.
HK1037617A1 (en) Process for the preparation of imidazodiazepine intermediates
AU2002255473A1 (en) Process for preparing intermediates of hiv protease inhibitors
GB0320738D0 (en) Novel process
MXPA03011647A (en) Resolution process for (r)-(-)-2-hydroxy-2-(2-chlorophenyl) acetic acid.
AU7214298A (en) Process for making a butylthio-isoquinoline and intermediates therefor
EP1215193A3 (en) Production of 2-hydrocarbyl-2-adamantyl acrylate compounds
AU2001253602A1 (en) Synthesis of intermediates useful in preparing tricyclic compounds
MXPA04003086A (en) A process for the stereoselective synthesis of 2-hydroxymethyl-chromans.
AU2002368494A1 (en) A process for the preparation of cefpodoxime proxetil
HUP0203214A3 (en) Process for preparing intermediates applicable for synthesis of hiv protease inhibitor
AU4865201A (en) An intermediate and process for its synthesis